Cargando…
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
BACKGROUND: Subtypes are widely found in cancer. They are characterized with different behaviors in clinical and molecular profiles, such as survival rates, gene signature and copy number aberrations (CNAs). While cancer is generally believed to have been caused by genetic aberrations, the number of...
Autores principales: | Chen, Peikai, Fan, Yubo, Man, Tsz-kwong, Hung, YS, Lau, Ching C, Wong, Stephen TC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820164/ https://www.ncbi.nlm.nih.gov/pubmed/24564171 http://dx.doi.org/10.1186/1471-2105-14-S18-S1 |
Ejemplares similares
-
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
por: Kool, Marcel, et al.
Publicado: (2008) -
Clinical and Molecular Features in Medulloblastomas Subtypes in Children in a Cohort in Taiwan
por: Wu, Kuo-Sheng, et al.
Publicado: (2022) -
The whole-genome landscape of medulloblastoma subtypes
por: Northcott, Paul A., et al.
Publicado: (2017) -
MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS
por: Pugh, Trevor J., et al.
Publicado: (2012) -
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes
por: Liang, Lisa, et al.
Publicado: (2015)